Such results derived from the primary endometrial carcinoma were also confirmed at cellular levels or in a xenograft model in which dietary addition of ω-3 PUFAs or mfat-1 expression inhibited the growth of cultured or implanted RL95-2 cells carrying a PTEN null mutation. This evidence concerns the gene PTEN and endometrial carcinoma.